How we do it - A practical approach to hepatic metastases ablation techniques

Techniques in Vascular and Interventional Radiology

Volumn 16, Issue 4, 2013, Pages 219-229

  Sofocleous, Constantinos T ^a   Sideras, Panagiotis ^a   Petre, Elena N ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Ablation techniques; Cryoablation; Microwave ablation; Percutaneous ablation; Radiofrequency ablation; Thermal ablation

Indexed keywords

ANTIBIOTIC AGENT; ARGON; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN A; IBUPROFEN; LIQUID NITROGEN;

ABLATION THERAPY; ANESTHESIA INDUCTION; ANTIBIOTIC PROPHYLAXIS; BILE DUCT INJURY; BREAST METASTASIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CELL DEATH; CELL MEMBRANE PERMEABILITY; CLINICAL EVALUATION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CRYOABLATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ELECTROPORATION; FEVER; FOLLOW UP; HUMAN; IMAGE GUIDED BIOPSY; IRREVERSIBLE ELECTROPORATION; LENGTH OF STAY; LIVER ABSCESS; LIVER FAILURE; LIVER METASTASIS; LOW LEVEL LASER THERAPY; MICROWAVE THERAPY; MULTIPLE ORGAN FAILURE; OCCLUSION BALLOON CATHETER; PNEUMOTHORAX; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE NAUSEA; POSTOPERATIVE PAIN; RADIATION INJURY; RADIATION SAFETY; RADIOFREQUENCY ABLATION; REVIEW; THERMAL INJURY; THORAX DRAINAGE; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; TISSUE PERFUSION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR LYSIS SYNDROME; TUMOR SEEDING; TUMOR VOLUME;

ABLATION TECHNIQUES; CRYOABLATION; MICROWAVE ABLATION; PERCUTANEOUS ABLATION; RADIOFREQUENCY ABLATION; THERMAL ABLATION;

ABLATION TECHNIQUES; HUMANS; LIVER NEOPLASMS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SURGERY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84887601657     PISSN: 10892516     EISSN: 15579808     Source Type: Journal    
DOI: 10.1053/j.tvir.2013.08.005     Document Type: Review

References (52)

1. McCarley J.R., Soulen M.C. Percutaneous ablation of hepatic tumors. Semin Intervent Radiol 2010, 27:255-260.
2. Sorensen J.B., Klee M., Palshof T., et al. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer 1993, 67:773-775.
3. Gomaa A.I., Khan S.A., Leen E.L., et al. Diagnosis of hepatocellular carcinoma. World J Gastroenterol 2009, 15:1301-1314.
4. Pua B.B., Sofocleous C.T. Imaging to optimize liver tumor ablation. Imaging Med 2010, 2:433-443.
5. Gillams A.R., Lees W.R. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004, 14:2261-2267.
6. Izzo F. Other thermal ablation techniques: Microwave and interstitial laser ablation of liver tumors. Ann Surg Oncol 2003, 10:491-497.
7. Lee E.W., Chen C., Prieto V.E., et al. Advanced hepatic ablation technique for creating complete cell death: Irreversible electroporation. Radiology 2010, 255:426-433.
8. Allaf M.E., Varkarakis I.M., Bhayani S.B., et al. Pain control requirements for percutaneous ablation of renal tumors: Cryoablation versus radiofrequency ablation-Initial observations. Radiology 2005, 237:366-370.
9. Ryan ER, Sofocleous CT, Schoder H, et al.: "Split-dose" technique for FDG PET-CT guided percutaneous ablation: A method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. Radiology 268:288-295, 2013 doi: 10.1148/radiol.13121462. Epub 2013 Apr 5.
10. Hinshaw J.L., Laeseke P.F., Winter T.C., et al. Radiofrequency ablation of peripheral liver tumors: Intraperitoneal 5% dextrose in water decreases postprocedural pain. AJR Am J Roentgenol 2006, 186:S306-S310.
11. de Baere T., Bessoud B., Dromain C., et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. AJR Am J Roentgenol 2002, 178:53-59.
12. Ross W.B., Horton M., Bertolino P., et al. Cryotherapy of liver tumours-A practical guide. HPB Surg 1995, 8:167-173.
13. Seifert J.K., Stewart G.J., Hewitt P.M., et al. Interleukin-6 and tumor necrosis factor-alpha levels following hepatic cryotherapy: Association with volume and duration of freezing. World J Surg 1999, 23:1019-1026.
14. Deodhar A., Brody L.A., Brown K.T., et al. Management of sepsis and recurrent abscess formation complicating radiofrequency ablation of pancreatic cancer liver metastasis and whipple resection. J Intervent Oncol 2010, 3:17-22.
15. Shibata T., Yamamoto Y., Yamamoto N., et al. Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: Incidence and risk factors. J Vasc Intervent Radiol 2003, 14:1535-1542.
16. Hoffmann R., Rempp H., Schmidt D., et al. Prolonged antibiotic prophylaxis in patients with bilioenteric anastomosis undergoing percutaneous radiofrequency ablation. J Vasc Intervent Radiol 2012, 23:545-551.
17. Chang I.S., Rhim H., Kim S.H., et al. Biloma formation after radiofrequency ablation of hepatocellular carcinoma: Incidence, imaging features, and clinical significance. AJR Am J Roentgenol 2010, 195:1131-1136.
18. Fox J.P., Gustafson J., Desai M.M., et al. Short-term outcomes of ablation therapy for hepatic tumors: Evidence from the 2006-2009 nationwide inpatient sample. Ann Surg Oncol 2012, 19:3677-3686.
19. Livraghi T., Solbiati L., Meloni M.F., et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study. Radiology 2003, 226:441-451.
20. Takaki H., Yamakado K., Nakatsuka A., et al. Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: Single-center experience. AJR Am J Roentgenol 2013, 200:658-664.
21. Miller A.B., Hoogstraten B., Staquet M., et al. Reporting results of cancer treatment. Cancer 1981, 47:207-214.
22. Jain R.K., Lee J.J., Ng C., et al. Change in tumor size by RECIST correlates linearly with overall survival in phase i oncology studies. J Clin Oncol 2012, 30:2684-2690.
23. Wahl R.L., Jacene H., Kasamon Y., et al. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med 2009, 50(suppl 1):122S-150S.
24. Livraghi T., Solbiati L., Meloni F., et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer 2003, 97:3027-3035.
25. Mulier S., Ni Y., Jamart J., et al. Radiofrequency ablation versus resection for resectable colorectal liver metastases: Time for a randomized trial?. Ann Surg Oncol 2007, 15:144-157.
26. Sofocleous C.T., Petre E.N., Gonen M., et al. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Intervent Radiol 2011, 22:755-761.
27. Umeda Y., Matsuda H., Sadamori H., et al. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection. World J Surg 2011, 35:170-177.
28. Solbiati L., Livraghi T., Goldberg S.N., et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology 2001, 221:159-166.
29. Lencioni R., Crocetti L., Cioni D., et al. Percutaneous radiofrequency ablation of hepatic colorectal metastases: Technique, indications, results, and new promises. Invest Radiol 2004, 39:689-697.
30. Sofocleous C.T., Klein K.M., Hubbi B., et al. Histopathologic evaluation of tissue extracted on the radiofrequency probe after ablation of liver tumors: Preliminary findings. AJR Am J Roentgenol 2004, 183:209-213.
31. Snoeren N., Jansen M.C., Rijken A.M., et al. Assessment of viable tumour tissue attached to needle applicators after local ablation of liver tumours. Dig Surg 2009, 26:56-62.
32. Sofocleous C.T., Nascimento R.G., Petrovic L.M., et al. Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: Initial results. Radiology 2008, 249:364-374.
33. Snoeren N., Huiskens J., Rijken A.M., et al. Viable tumor tissue adherent to needle applicators after local ablation: A risk factor for local tumor progression. Ann Surg Oncol 2011, 18:3702-3710.
34. Sofocleous C.T., Garg S., Petrovic L.M., et al. Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Ann Surg Oncol 2012.
35. Malik H.Z., Hamady Z.Z., Adair R., et al. Prognostic influence of multiple hepatic metastases from colorectal cancer. Eur J Surg Oncol 2007, 33:468-473.
36. Pawlik T.M., Schulick R.D., Choti M.A. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008, 13:51-64.
37. Solbiati L., Ahmed M., Cova L., et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: Local response rate and long-term survival with up to 10-year follow-up. Radiology 2012, 265:958-968.
38. Oshowo A., Gillams A., Harrison E., et al. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003, 90:1240-1243.
39. Hur H., Ko Y.T., Min B.S., et al. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg 2009, 197:728-736.
40. Erinjeri J.P., Fong A.J., Kemeny N.E., et al. Timing of administration of bevacizumab chemotherapy affects wound healing after chest wall port placement. Cancer 2011, 117:1296-1301.
41. Pathak S., Jones R., Tang J.M., et al. Ablative therapies for colorectal liver metastases: A systematic review. Colorectal Dis 2011, 13:e252-e265.
42. Atalay G., Biganzoli L., Renard F., et al. Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: A retrospective analysis of two prospective, randomised metastatic breast cancer trials. Eur J Cancer 2003, 39:2439-2449.
43. Sofocleous C.T., Nascimento R.G., Gonen M., et al. Radiofrequency ablation in the management of liver metastases from breast cancer. AJR Am J Roentgenol 2007, 189:883-889.
44. Meloni M.F., Andreano A., Laeseke P.F., et al. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation-Intermediate and long-term survival rates. Radiology 2009, 253:861-869.
45. Jakobs T.F., Hoffmann R.T., Schrader A., et al. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. Cardiovasc Intervent Radiol 2009, 32:38-46.
46. Bergenfeldt M., Jensen B.V., Skjoldbye B., et al. Liver resection and local ablation of breast cancer liver metastases-A systematic review. Eur J Surg Oncol 2011, 37:549-557.
47. Vogl T.J., Farshid P., Naguib N.N., et al. Thermal ablation therapies in patients with breast cancer liver metastases: A review. Eur Radiol 2013, 23:797-804.
48. Rohde D., Albers C., Mahnken A., et al. Regional thermoablation of local or metastatic renal cell carcinoma. Oncol Rep 2003, 10:753-757.
49. Mazzaglia P.J., Berber E., Milas M., et al. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: A 10-year experience evaluating predictors of survival. Surgery 2007, 142:10-19.
50. Berber E., Ari E., Herceg N., et al. Laparoscopic radiofrequency thermal ablation for unusual hepatic tumors: Operative indications and outcomes. Surg Endosc 2005, 19:1613-1617.
51. Derek E., Matsuoka L., Alexopoulos S., et al. Combined surgical resection and radiofrequency ablation as treatment for metastatic ocular melanoma. Surg Today 2013, 43:367-371.
52. Langan R.C., Ripley R.T., Davis J.L., et al. Liver directed therapy for renal cell carcinoma. J Cancer 2012, 3:184-190.